Active	Status	Sponsor type	Region	Phase	Filter
10 Active 8 Inactive 18 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Shi, Yuan
NCT02698111: Donafenib Monotherapy for Previously Treated Metastatic Nasopharyngeal Carcinoma	Terminated	1/2	20	RoW	Donafenib, CM4307	Suzhou Zelgen Biopharmaceuticals Co.,Ltd	Nasopharyngeal Carcinoma	10/21	10/21
Wu, Gaohong
No trials found